Seattle, Sept. 06, 2022 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the pediatric antibiotacs market is estimated at WE$6,478.9 million in 2022 and should present a CAGR of 2.3% during the forecast period (2022-2030).
Key trends and analysis of Global Pediatric Antibiotacs market:
Key market trends include increasing launches of antibiotic awareness campaigns which is expected to drive the market growth over the forecast period. For example, in November 2019, the state of Kerala in India, as part of its Antimicrobial Resistance Strategic Action Plan (KARSAP), launched a mega public awareness campaign on antibiotics.
Request a sample copy of this report @ https://www.coherentmarketinsights.com/insight/request-sample/5190
Main market takeaways:
The global pediatric antibiotics market is expected to grow at a CAGR of 2.3% during the forecast period owing to the increase in strategic collaborations of organizations for the development of pediatric antibiotic treatment, which is expected to drive the growth of the global pediatric antibiotics market over the forecast period. For example, in March 2019, the Global Antibiotic Research & Development Partnership (GARDP), a nonprofit research and development (R&D) organization, and Penta, the pediatric infectious disease research network, joined together to fight against drug-resistant infections. in children. The strategic collaboration aims to accelerate the development of pediatric antibiotic treatments, including: clinical trials designed to meet regulatory requirements; and trials focusing on public health interventions to inform treatment guidelines.
Among the routes of administration, the intravenous segment is expected to hold a dominant position in the global pediatric antibiotics market during the forecast period, owing to the increase in product approvals which is expected to drive the market growth during the forecast period. the forecast period. For example, in July 2021, AbbVie, a research-based biopharmaceutical company, announced that the United States Food and Drug Administration (FDA) had approved DALVANCE (dalbavancin) for the treatment of acute bacterial infections of the skin and cutaneous structures (ABSSSI) in pediatric patients from birth. DALVANCE is the first single-dose option given as a 30-minute intravenous (IV) infusion for the treatment of ABSSSI caused by designated susceptible Gram-positive bacteria in pediatric patients, including infections caused by methicillin-resistant Staphylococcus aureus ( MRSA). DALVANCE is the first and only IV antibiotic approved for the treatment of ABSSSI with a single dose regimen based on age and weight in pediatric patients, each administered over 30 minutes.
Based on the region, North America is estimated to hold a dominant position in the global pediatric antibiotics market during the forecast period owing to the increase in research and development of pediatric antibiotics. For example, on April 6, 2022, Paratek Pharmaceuticals Inc., a biopharmaceutical company, initiated a multicenter, open-label, Phase 1 study to evaluate the safety, tolerability, and pharmacokinetics of single intravenous and oral doses of omadacycline in pediatric subjects. Suspected or confirmed bacterial infections. Omadacycline is a tetracycline antibiotic used to treat community-acquired bacterial pneumonia. This study is expected to be completed by June 2022.
Competitive Landscape:
The major players operating in the global pediatric antibiotics market are Johnson & Johnson, Astellas Pharma, Inc, Pfizer Inc., Novartis AG, Bayer AG, Bristol-Myers Squibb Company, Abbott., DAIICHI SANKYO COMPANY, LIMITED, Dr. Reddy’s Laboratories Ltd, Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA, GlaxoSmithKline Plc., Hikma Pharmaceuticals PLC, Cipla Inc., Glenmark Pharmaceuticals and Torrent Pharmaceuticals Ltd.
Buy now this research report @ https://www.coherentmarketinsights.com/insight/buy-now/5190
Market segmentation :
- Global Pediatric Antibiotics Market, By Infection:
- Acute sinusitis
- Acute otitis media
- Non-specific upper respiratory tract infections
- Urinary tract infections
- Others
- Global Pediatric Antibiotics Market, By Route Of Administration:
- Oral
- Topical
- Intravenous
- Others
- Global Pediatric Antibiotics Market, By Distribution Channel:
- Hospital pharmacies
- Retail pharmacies
- E-commerce
- Global Pediatric Antibiotics Market, By Region:
- North America
- Latin America
- By country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By country
- Europe
- By country
- Germany
- UK
- France
- Italy
- Spain
- Russia
- The rest of Europe
- By country
- Asia Pacific
- By country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia-Pacific
- By country
- Middle East
- By country
- GCC
- Israel
- Rest of the Middle East
- By country
- Africa
- By country
- South Africa
- central Africa
- North Africa
- By country
Related Market Information Reports:
nasal polyps treatment marketby drug class, (corticosteroids, (nasal corticosteroids, fluticasone, budesonide, mometasone, triamcinolone, others – beclomethasone, ciclesonide, etc.), oral/injectable corticosteroids (prednisone, combination), antibiotics, antihistamines, interleukin inhibitors, (dupilumab, Others (IL 10, IL 25 etc.)), Monoclonal antibodies, (Mepolizumab, Omalizumab, Others), Others (Aspirin, anticholinergic agent and etc.)), by route of administration (nasal, oral, parenteral) , by distribution channel (hospital pharmacies, retail pharmacies, online pharmacies) and by region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) – Analysis of the size, share, prospects and opportunities, 2022 – 2030
Acne Drugs Marketby formulation (topical, oral, and parenteral), by product type (antibiotics, salicylic acid, benzoyl peroxide, azelaic acid, anti-androgens, dapsone, and others), by type (prescription and over-the-counter), by type (Inflammatory Acne and Non-Inflammatory Acne), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others) and Region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) – Size, Share, Outlook and Opportunity Analysis, 2022 – 2030
About Us:
Consistent market information is a global market intelligence and advisory organization focused on helping our plethora of clients achieve transformational growth by helping them make critical business decisions. Our head office is in India, with a sales office in the world’s financial capital in the USA and sales advisors in the UK and Japan. Our customer base includes players from various industries in more than 57 countries around the world. We create value for our clients through our highly reliable and accurate reports. We are also committed to playing a leadership role in providing insights in various post-COVID-19 sectors and to continuing to deliver measurable and sustainable results to our clients.
Follow us: LinkedIn | Twitter
Comments are closed.